Blog Archive
-
▼
2008
(297)
-
▼
January
(16)
- Transgene's Therapeutic Vaccine TG4010, Phase IIb ...
- Agennix, Pivotal Trial of Talactoferrin Alfa in Fi...
- Peregrine Pharmaceuticals, Approval to Conduct a P...
- Vapotherm, Patent For Apparatus And Method For Res...
- Serenex, to Evaluate Proprietary Small Molecule Hs...
- Kamada, Phase I Studies with Aerosolized AAT for t...
- 20/20 GeneSystems, Licenses Lung Cancer Blood Test...
- PhytoMedical, Patented Anti-Cancer Compounds Kill ...
- Pharmaxis, Aridol, first Asian Approval
- Nycomed, ALVESCO , FDA approval for the U.S. market
- Aeras and Crucell, Start of a Tuberculosis Vaccine...
- Exelixis, Phase 1/2 Trial of XL184 in Patients Wit...
- Genzyme, License Agreement with Moffitt Cancer Cen...
- Luminex , FDA Clearance for xTAG Respiratory Viral...
- GlaxoSmithKline and Theravance, 642444 and 685698...
- Alnylam, Progress in Clinical Development of ALN-R...
-
▼
January
(16)
Jan 17, 2008
Pharmaxis, Aridol, first Asian Approval
